Get in touch

Latest Updates

News, Stories & Healthcare Insights

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.
  • News

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new...

Tiefenbacher Group - A scientist wearing safety goggles and a lab coat closely observes equipment in a laboratory focused on patient-centric drug development, surrounded by scientific instruments and glassware.
  • News

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The...

Tiefenbacher Group - A young girl wearing glasses and a white lab coat smiles and points upward, standing next to the text "Tiefenbacher Medical Devices," representing innovative pharmaceutical healthcare solutions on a light background.
  • News

TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES

Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device business into a new...

Tiefenbacher Group - Hands holding soil with a small green seedling, surrounded by digital chemical formulas and hexagons, with sunlight shining in a blurred green background, symbolizing science and growth in pharmaceutical healthcare solutions.
  • News

TIEFENBACHER API + INGREDIENTS: FIRST API BASED ON GREEN CHEMISTRY

TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistryWe at TIEFENBACHER API + INGREDIENTS are committed to drive greem chemistry in the pharmaceutical raw...

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.
  • News

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic...

Tiefenbacher Group - A large group of people, including men and women in formal and colorful traditional attire, stand on a grassy lawn with a modern glass building behind them, reflecting the unity of a family-owned pharmaceutical company dedicated to patient-centric drug development.
Tiefenbacher Group - A white play button icon centered within a blue hexagon on a light gray background, representing pharmaceutical healthcare solutions.
  • News

AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole

AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval...

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.
  • News

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for...

Tiefenbacher Group - A man in a dark suit and glasses sits on a chair by a large window overlooking modern office buildings and a waterfront. He is smiling, has short, light hair, and projects the professionalism of a family-owned pharmaceutical company.
  • News

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before”We are very excited to launch the new Tiefenbacher Group website. It represents the...

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.
  • News

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop...

Tiefenbacher Group - A group of about 20 people poses and smiles outdoors under a rainbow decoration, with trees and a building in the background. The blue border features the "Tiefenbacher Group" logo, highlighting their focus on patient-centric drug development.
  • News

TIEFENBACHER GROUP SUMMER EVENT 2023

For our Tiefenbacher Group Social Day we have given our employees in #hamburg time off so that they can get socially involved in an institution in the Hanseatic city....

Get in touch